BIGBEAR
PHARMACEUTICALS
Brain Metastasis Buster.
Drug-Resistant Mutation Terminator.
AuthenticGuaranteeFast DeliveryPrivacy What are the adverse reactions of loratinib?Everyone's physical condition is different, and the possible adverse reactions may vary. Pay close att···【Read More】
Update: 13 Mar,2026Source: Haiou HealthViews: 70
What are the available dosage forms and strengths of loratinib?Loratinib is currently only available in tablet form, with two different strengths:25mg···【Read More】
Update: 13 Mar,2026Source: Haiou HealthViews: 70
Which drugs may interact with loratinib?Special attention should be paid to interactions with other medications during treatment.Potent CYP3A inducers···【Read More】
Update: 13 Mar,2026Source: Haiou HealthViews: 70
Who should use loratinib with caution?The following four groups of people are at higher risk when using this medication and need to exercise special c···【Read More】
Update: 13 Mar,2026Source: Haiou HealthViews: 70
What medications are commonly used in conjunction with loratinib?Because targeted therapies carry the risk of interactions, patients should not self-m···【Read More】
Update: 13 Mar,2026Source: Haiou HealthViews: 70
Function and efficacy ofLorlatinibLoratinib is a targeted therapy drug for a specific type of lung cancer. Its main component is an anaplastic lymphom···【Read More】
Update: 13 Mar,2026Source: Haiou HealthViews: 70
Lorlatinib, the world's first third-generation ALK (anaplastic lymphoma kinase)/ROS1 tyrosine kinase inhibitor (TKI), was developed by Pfizer for ···【Read More】
Update: 05 Mar,2026Source: Haiou HealthViews: 71
Lorlatinib was approved for marketing in China by the National Medical Products Administration (NMPA) in April 2022 and has been included in the Natio···【Read More】
Update: 05 Mar,2026Source: Haiou HealthViews: 71
Lorlatinib is a novel third-generation small-molecule ALK/ROS1 dual-target inhibitor developed by Pfizer Inc.Side effects requiring immediate medical ···【Read More】
Update: 05 Mar,2026Source: Haiou HealthViews: 71
Lorlatinib was first approved for marketing in Japan in September 2018, followed by approval from the U.S. Food and Drug Administration (FDA) in Novem···【Read More】
Update: 05 Mar,2026Source: Haiou HealthViews: 72
Copyright2024@ BIGBEAR All right reserved BIGBEAR
